Ekta Patel

Ekta Patel

Company: Xilio Therapeutics

Job title: Director – Translational

Seminars:

Engineering Cytokine Activation: Identification & Development of XTX301, a Tumor Selective IL-12 For Immunotherapy of Cancer 2:30 pm

Learn about XTX301, a masked IL-12 in systemic circulation until cleaved by proteases in the tumor microenvironment Explore how murine surrogate of XTX301 demonstrates efficacy and tumor selective activity in syngeneic mouse models Discuss how XTX301 was well-tolerated in a repeat dose non-human primate safety studyRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.